Back to search

Article

The multi-Siglec inhibitor AL009 reprograms suppressive macrophages and activates innate and adaptive tumor immunity

2023-08-05

Abstract excerpt

Sialic acid–binding immunoglobulin-type lectins (Siglecs) are cell surface receptors that regulate innate and adaptive immunity, with inhibitory Siglecs promoting immune tolerance. In the tumor microenvironment, overexpression of sialic acid glycans exploits inhibitory Siglec signaling, leading to a cancer-permissive phenotype. AL009 is an engineered Siglec-9-Fc fusion molecule that functions as a sialic acid trap...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c842cd7a-13e6-52da-be2e-442b8ad68078
DOI
10.1101/2023.08.02.551627
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The multi-Siglec inhibitor AL009 reprograms suppressive macrophages and activates innate and adaptive tumor immunityDOI 10.1101/2023.08.02.551627
Select a neighboring publication to make it the new centre.